Medius Holdings Grows Sales but Sees Profit Decline, Keeps FY2026 Forecast Unchanged

Medius Holdings Co., Ltd. ( (JP:3154) ) just unveiled an announcement.

Medius Holdings reported first-half fiscal 2025 consolidated net sales of ¥149.2 billion, up 4.6% year on year, but operating profit fell 22.1% to ¥585 million and profit attributable to owners of parent slipped 4.8% to ¥387 million, reflecting weaker profitability despite higher revenue. Total assets rose to ¥127.6 billion while the equity ratio declined to 15.9%, and earnings per share edged down to ¥17.41, with the company maintaining its interim dividend at zero and planning a full-year dividend of ¥20 per share.

For the full year ending June 2026, Medius kept its earnings forecast unchanged, projecting net sales of ¥305 billion, up 5.6%, but expecting declines in operating and ordinary profit and net income of around 5–7%, signaling continued margin pressure. The group also reported a change in consolidation scope, adding REPS Corp. and removing NOAH INTERNATIONAL co., ltd., indicating ongoing portfolio adjustments that may influence future performance and strategic positioning.

The most recent analyst rating on (JP:3154) stock is a Hold with a Yen855.00 price target. To see the full list of analyst forecasts on Medius Holdings Co., Ltd. stock, see the JP:3154 Stock Forecast page.

More about Medius Holdings Co., Ltd.

Medius Holdings Co., Ltd., listed on the Tokyo Stock Exchange Prime Market under code 3154, operates as a diversified group in Japan, reporting consolidated results under Japan GAAP. The company manages multiple consolidated subsidiaries and focuses on steady revenue growth while maintaining shareholder returns through stable dividend policies.

Average Trading Volume: 19,420

Technical Sentiment Signal: Buy

Current Market Cap: Yen18.01B

For detailed information about 3154 stock, go to TipRanks’ Stock Analysis page.